Unfortunately that's the reason we need to have double blinded controlled clinical trials. Because we can't be sure what part of the treatment actually contributed to the patient's perception of pain relief. It's dependent on a multitude of factors that need to be controlled for. And if you are postulating a physical change is responsible, then you would perhaps hope for some functional improvement
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-374
-
- There are more pages in this discussion • 730 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.5¢ |
Change
-0.050(5.03%) |
Mkt cap ! $1.093B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.5¢ | $2.357M | 2.440M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 143047 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 134570 | 54 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 133662 | 0.945 |
23 | 240143 | 0.940 |
13 | 113588 | 0.935 |
13 | 249134 | 0.930 |
5 | 510290 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 143862 | 51 |
0.955 | 91605 | 12 |
0.960 | 80682 | 7 |
0.965 | 37546 | 5 |
0.970 | 20159 | 2 |
Last trade - 15.52pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |